Vanderbilt University Medical Center investigators have joined forces with scientists at Incyte Corp. to explore new therapies for the treatment of various types of cancer, as well as other diseases. The company has agreed to help fund basic and translational science research by VUMC investigators. Read More
Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys. Read More
Three areas of Vanderbilt University Medical Center won Top Performer Awards in the 2015 Excellence in Healthcare Award, sponsored by Professional Research Consultants Inc. (PRC), Vanderbilt’s patient satisfaction surveyor until recently. Read More
Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation. Read More
Jeffrey Rathmell, Ph.D., has been recruited to Vanderbilt University Medical Center (VUMC) to lead a new Center for Immunobiology, a structure supported by the Department of Pathology, Microbiology and Immunology, the Department of Medicine and Vanderbilt-Ingram Cancer Center (VICC). Read More
Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities. Read More
Debra Friedman, M.D., director of Pediatric Hematology/Oncology and E. Bronson Ingram Professor of Pediatric Oncology, has received a $50,000 Hyundai Hope On Wheels Impact grant recently for her track record in providing excellent patient care to families affected by pediatric cancer and to support a pediatric cancer program aimed at developing innovative therapies. Read More
With a basketball tucked under his arm, 7-year-old Roger Waynick climbed on top of his dad’s black Tahoe SUV with the intention of sailing upward through the air toward the basketball goal. He was poised to make the most epic dunk ever. Read More
Carrie Kitko, M.D., has joined Monroe Carell Jr. Children’s Hospital at Vanderbilt as associate professor of Pediatrics and director of the Pediatric Stem Cell Transplant Program in the Division of Hematology/Oncology. Read More
Twenty-eight retiring faculty members were recognized during Vanderbilt’s Commencement ceremony May 8, when the university honored their years of service and bestowed on them the title of emeritus or emerita faculty. Read More
Douglas Johnson, M.D. Douglas Johnson, M.D., assistant professor of Medicine, has been named a recipient of the National Comprehensive Cancer… Read More
Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators. Read More
When something attacks you, you want to attack it back. That’s how Lillian “Tooty” Bradford views her late husband James “Jimmy” Bradford Jr.’s decision to make an initial gift to fund melanoma research at Vanderbilt-Ingram Cancer Center (VICC). Read More
The Nashville Predators Foundation recently presented a $318,242 check to Monroe Carell Jr. Children’s Hospital at Vanderbilt for the 365 Pediatric Cancer Fund. Read More
A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways. Read More
Michael R. DeBaun, M.D., MPH, has been recognized by the American Society of Hematology (ASH) for his significant contributions and research advances in the area of sickle cell disease. Read More
Two new services focused on treating infectious diseases in children started this month at the Monroe Carell Jr. Children’s Hospital at Vanderbilt, including one that cares solely for children with compromised immune systems. Read More
The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology. Read More
Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). Read More
Sally York, M.D., Ph.D. Sally York, M.D., Ph.D., assistant professor of Medicine in the Division of Hematology and Oncology,… Read More
